AngioDynamics, founded in 1988 and headquartered in Queensbury, is a leading provider of innovative medical devices. The company specializes in products used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. Operating in the high-growth, technologically competitive medical device industry, AngioDynamics has established itself as a dynamic brand and is publicly traded on NASDAQ.

The company's business model revolves around the development, manufacturing, and sale of medical devices that facilitate minimally invasive procedures. These devices are designed to improve patient outcomes and reduce recovery times, making them highly valuable to healthcare providers. AngioDynamics generates revenue through the direct sale of its products to hospitals, clinics, and other healthcare facilities, as well as through partnerships and distribution agreements.

AngioDynamics serves a diverse client base, including interventional radiologists, interventional cardiologists, surgeons, and other medical professionals who require advanced tools for diagnosing and treating complex medical conditions. The company's market includes the broader healthcare sector, with a focus on oncology and vascular disease treatment.

Keywords: medical devices, minimally invasive, cancer treatment, vascular disease, interventional radiology, interventional cardiology, surgeons, healthcare, NASDAQ, high-growth industry.